Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Croma-Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10936
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products comprise princess skincare masks and princess skincare serums. Croma Pharma’s princess lift products include happy lift and PDO. The company distributes its products in countries through its own commercial sales organization and through strategic partnerships and distributors. It has its operations in Canada, Germany, Austria, Belgium, Brazil, Poland, Romania, France, the Netherlands, Spain, and the US. Croma Pharma is headquartered in Leobendorf, Austria.

Croma-Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Croma-Pharma Forms Joint Venture with Hugel 11
Croma Pharma Enters Into Distribution Agreement With Hugel 12
Licensing Agreements 13
Croma-Pharma Enters into Licensing Agreement with Universkin 13
Asset Transactions 14
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 14
Croma-Pharma GmbH – Key Competitors 15
Croma-Pharma GmbH – Key Employees 16
Croma-Pharma GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croma-Pharma Forms Joint Venture with Hugel 11
Croma Pharma Enters Into Distribution Agreement With Hugel 12
Croma-Pharma Enters into Licensing Agreement with Universkin 13
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 14
Croma-Pharma GmbH, Key Competitors 15
Croma-Pharma GmbH, Key Employees 16
Croma-Pharma GmbH, Subsidiaries 17

List of Figures
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siemens AG (SIE):石油・ガス:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Quanterix Corp (QTRX):企業の製品パイプライン分析2018
    Summary Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company’s products include biomarker detection system, assay kits, single molecule detector and analyzers. It provides clinical sample and outsourced testing, custom assay development, …
  • San Miguel Brewery Hong Kong Ltd.:企業の戦略・SWOT・財務分析
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Silence Therapeutics Plc (SLN)-製薬・医療分野:企業M&A・提携分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for …
  • Matrix IT Ltd (MTRX):企業の財務・戦略的SWOT分析
    Matrix IT Ltd (MTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fortum Corporation (FORTUM):電力:M&Aディール及び事業提携情報
    Summary Fortum Corporation (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power pl …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • Emera Inc (EMA):電力:M&Aディール及び事業提携情報
    Summary Emera Inc (Emera) is an energy and services company. It invests in electricity, natural gas and utility energy services. Through ownership and equity investments in various companies, Emera generates, transmits and distributes electricity; procures, transmits and distributes natural gas; mar …
  • Evolva Holding SA:企業の戦略・SWOT・財務情報
    Evolva Holding SA - Strategy, SWOT and Corporate Finance Report Summary Evolva Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Allied Cooperative Insurance Group:企業の戦略・SWOT・財務情報
    Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務分析
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Terumo Corporation:企業の戦略・SWOT・財務情報
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ICA Gruppen AB:企業のM&A・事業提携・投資動向
    ICA Gruppen AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICA Gruppen AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Ascent Solar Technologies Inc (ASTI)-エネルギー分野:企業M&A・提携分析
    Summary Ascent Solar Technologies, Inc. (Ascent solar) is a developer and manufacturer of thin-film photovoltaic modules using substrate materials. It develops products by using thin-film copper-indium-gallium- diselenide (CIGS) photovoltaic technology. The product portfolio of the company includes …
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • CLP Holdings Limited:企業の戦略・SWOT・財務分析
    CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aviva Poland:企業の戦略・SWOT・財務情報
    Aviva Poland - Strategy, SWOT and Corporate Finance Report Summary Aviva Poland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆